US Private Equity Mergers Regulations 2026: What’s Really Changing and Why It Matters

If you’ve been trying to keep up with the us private equity mergers regulations 2026, you’re not alone. Things moved fast this year. A big court ruling, a scrapped rule, and a fresh call for public comment all landed within a few short months.

Here’s the thing: the rules that govern how deals get reviewed are in flux right now. And for anyone buying, selling, or advising on companies, that matters a lot.

Let me walk you through what happened, what regulators are eyeing next, and what it means for private equity firms.

A Quick Overview of Where Things Stand

The us private equity mergers regulations 2026 story really comes down to the premerger notification process. That’s the system where companies tell the government about a deal before they close it.

The core law behind it hasn’t changed. But the paperwork and the enforcement focus? Those are shifting. And 2026 has been a bumpy ride so far.

Background: The Hart-Scott-Rodino Act Explained

To understand the us private equity mergers regulations 2026, you have to start with the Hart-Scott-Rodino Act. It’s the backbone of merger review in the United States.

President Gerald Ford signed it into law back on September 30, 1976. It’s named after three lawmakers: senators Philip Hart and Hugh Scott, plus Representative Peter Rodino.

What the HSR Act Actually Does

In plain terms, the HSR Act says certain big deals can’t just close quietly. Both parties must file a “notification and report form” with the FTC and the DOJ’s Antitrust Division.

After filing, there’s a waiting period. Usually 30 days. During that window, regulators check whether the deal could hurt competition. If they need more info, they can ask for it through a “second request.”

Why It Only Applies to Bigger Deals

The filing rules kick in based on dollar thresholds. Small deals usually skip the process. Larger ones can’t. That threshold gets adjusted over time, so it climbs with inflation and market changes.

To be honest, this is where private equity firms have found room to maneuver over the years. More on that soon.

The February 2026 Court Ruling That Shook Things Up

Now the big one. In February 2026, a federal district court struck down a rule that had taken effect in February 2025. That rule expanded the amount of information companies had to report on the HSR form.

Then on March 19, 2026, the Fifth Circuit refused to pause the district court’s order while the FTC appealed. So the vacated rule stayed vacated.

What Happens to Filings Now

After the ruling, the FTC went back to accepting the older HSR form, the one used before the February 2025 changes. But it also said it would still accept the newer form if filers choose to use it voluntarily.

So there’s flexibility, at least for the moment. That’s an unusual spot for merger review to be in.

The March 25, 2026 Call for Public Comment

Here’s where it gets interesting. On March 25, 2026, the FTC and DOJ jointly announced they’re considering a new rulemaking process. Basically, a do-over on updating the premerger notification form.

The FTC didn’t back down on its core view, though. It said it still believes the nearly 50-year-old form isn’t enough to review modern mergers and acquisitions.

So the agencies asked the public to weigh in. They wanted feedback on the 2025 changes and whether those changes actually made reviews faster without piling on too much burden. Comments were due by May 26, 2026.

Key Focus Areas Regulators Want to Change

The request for information laid out several specific areas the agencies are thinking hard about. These matter a lot for the us private equity mergers regulations 2026 conversation.

Foreign Government and Foreign Investor Involvement

The agencies signaled they may require filers to disclose any CFIUS filings tied to a deal. They also want more detail on sovereign wealth funds and which governments back them.

For PE firms with overseas backers, that’s worth watching closely.

Defense and Military Supplier Contracts

The 2025 form asked about contracts with the U.S. military and intelligence agencies, but only when the parties overlapped. Now the agencies are considering asking about all such contracts, overlap or not, to protect the defense supply chain.

The Investment-Only Exemption

There’s an exemption that lets a buyer grab up to 10% of a company’s voting shares without filing, as long as it’s “solely for the purpose of investment.”

Regulators want to tighten how that’s read. They’re considering making clear the exemption doesn’t apply when an investor uses its stake to sway a company’s competitive decisions, like pricing or output.

Non-Traditional Deal Structures

This one’s sneaky. The agencies said they’ve seen more deals that don’t get reported but still wipe out a competitor. Think “acquihires,” reverse acquihires, and certain intellectual property license arrangements.

They also flagged convertible securities, which usually aren’t reportable but can effectively remove a rival. Expect scrutiny here.

Reporting on Structural Remedies

Sometimes parties offer fixes mid-review, like selling off assets to a buyer. The agencies don’t love when those remedies show up late, after litigation starts. So they’re weighing a separate or supplemental reporting step for proposed remedies.

Single-Family Housing Acquisitions

Following a January 2026 executive order, the agencies are looking at large institutional investors buying up single-family homes. They’re considering whether HSR rules should change to catch those local housing market roll-ups.

What This Means for Private Equity Firms

So how does all of this hit the private equity world? Directly, honestly.

PE firms have long used serial acquisitions and roll-up strategies. That means buying up lots of smaller companies in one sector to build scale. Many of those deals slipped under the reporting radar.

The Roll-Up and Serial Acquisition Squeeze

Regulators have made it clear they see roll-ups as a possible competition problem. When you stack up dozens of small buys, you can quietly dominate a market. The 2023 Merger Guidelines already recognized serial acquisitions can violate antitrust laws.

What’s interesting is that the focus on non-traditional structures and the investment exemption both point at PE playbooks. If the agencies tighten those rules, some buyouts that once flew under the radar may need filings.

More Paperwork, More Planning

For PE buyers, antitrust compliance is getting more complex. Deal teams need to think earlier about disclosure, foreign ties, and how a purchase fits into a broader acquisition history.

The lesson? Build antitrust review into your timeline from day one, not as an afterthought.

Enforcement Trends: Remedies Over Courtroom Fights

Here’s a shift worth noting. In vertical deals, the expectation for 2026 is continued scrutiny from the FTC and DOJ, but fewer full-blown court battles.

Instead, regulators seem more open to negotiating remedies. That could mean divestitures or behavioral commitments rather than dragging a case through trial.

For PE firms, that’s a mixed bag. On one hand, fewer lawsuits. On the other, more conditions attached to getting a deal done.

How to Stay Ready in a Shifting Landscape

The us private equity mergers regulations 2026 picture is still forming. The old form is back for now. A new rulemaking may be coming. And enforcement priorities keep sharpening around roll-ups and hidden deal structures.

My advice is simple. Watch the FTC and DOJ closely. Keep your antitrust compliance approach flexible. And don’t assume a small deal is automatically safe just because it once was.

Final Thoughts

The us private equity mergers regulations 2026 are a moving target, and that’s not likely to change soon. Between the court ruling, the paused form, and the fresh push for new rules, dealmakers have plenty to track.

If you want to really understand the foundation under all these changes, it helps to read up on the Hart–Scott–Rodino Antitrust Improvements Act. It’s the 1976 law that started it all, and knowing how it works makes the 2026 shifts a lot easier to follow. Stay curious, stay compliant, and keep an eye on what the agencies do next.

Continue reading: Harvard Common Data Set: Everything You Need to Know Before Applying